Near-infrared fluorescence imaging for intraoperative visualization of tumors by surgeons, leading to radical resection of tumor tissue
Intraoperative tumor imaging with SGM targeted molecules represents a real-time improvement in the intraoperative differentiation between normal and cancer tissue. It will participate in the new paradigm-shift in cancer surgery: surgeons will improve patient outcome while lowering health-care costs.
Turn a hidden threat into
a visible target
Our technology is based on tumor-specific antibodies conjugated to a near-infra-red dye. This injectable fluorescent dye has been optimized for the fluorescent image-guided surgery of small-size tumor nodules. After injection, the conjugated fix to the tumor surface markers. The fluorescent dye then act as a revelator, allowing visualization of micro-tumors and the radical tumor resection by the surgeon.Read more